医学
放射科
恶性肿瘤
甲状腺
癌胚抗原
肝门
甲状腺癌
外科
癌症
内科学
作者
Giuseppe Mamone,Settimo Caruso,Mariapina Milazzo,Roberto Miraglia
出处
期刊:Radiology
[Radiological Society of North America]
日期:2022-10-01
卷期号:305 (1): 242-246
标识
DOI:10.1148/radiol.210539
摘要
A 61-year-old woman was admitted to our institution to characterize an incidentally found mass in the porta hepatis. An episode of pulmonary embolism (18 months ago) and a pulmonary abscess (15 months ago) were reported. The patient had no history of known liver disease, previous cancer diagnosis, or trauma. She underwent total thyroidectomy for goiter several years ago, with initial iatrogenic hypothyroidism treated with levo-thyroxine hormone replacement therapy. During follow-up, this therapy was adjusted (50 μg per day) to induce euthyroidism and to achieve a target serum thyroid-stimulating hormone concentration of 1-2 mIU/L. Physical examination findings were unremarkable. Admission laboratory data were entirely normal, including tumor markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9. Unenhanced and multiphasic contrast-enhanced CT imaging was performed in arterial, portal venous, and delayed (3 minutes after injection) phases. Axial and coronal maximum intensity projection reconstructed CT images were obtained in the arterial and portal venous phases. Because of the imaging findings of the mass in the porta hepatis and concerns about malignancy, the patient underwent endoscopy. Therefore, endoscopic US-guided fine-needle biopsy was performed in the same session. The patient also underwent whole-body iodine 131 (131I) scintigraphy.
科研通智能强力驱动
Strongly Powered by AbleSci AI